Sold as Solatene. Every FDA application for this active ingredient.
As of Nov 15, 2026, FDA lists 1 application for Beta Carotene (sold as Solatene), with 0 new uses approved and 0 published complete response letters.
| Cannabidiol in Opioid Use Disorder and Chronic Pain With BuprenorphineChronic Pain, Opioid Use Disorder · Yale University | Early phase 1 | Recruiting | Oct 21, 2026 |
| Pilot Study of Naringenin Beta Carotene Cream for Local Fat Reduction (SCULPT)Thigh Cellulite · Frank Greenway | Not applicable | Not yet recruiting | Oct 7, 2026 |
| Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of EpendymomaChildhood Posterior Fossa Ependymoma · Children's Oncology Group | Phase 1 / Phase 2 | Not yet recruiting | Sep 30, 2026 |
| Algal Lutein Against Decline of Intellectual NimblenessMenopausal Syndrome, Cognitive Decline · Poznan University of Life Sciences | Not applicable | Not yet recruiting | May 20, 2026 |
| 9-cis Beta-Carotene-Rich Extract of Dunaliella Alga in Retinitis Pigmentosa PatientsRetinitis Pigmentosa · Sheba Medical Center | Phase 1 / Phase 2 | Enrolling by invitation | Apr 3, 2026 |
| Early Identification and Treatment of Rare Cardiomyopathy CohortsHypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM) · RenJi Hospital | Not applicable | Not yet recruiting | Jan 27, 2025 |
| Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaGanglioneuroblastoma, Nodular, Neuroblastoma · National Cancer Institute (NCI) | Phase 3 | Recruiting | Dec 15, 2023 |
| Effect of Eurycoma Longifolia (DLBS5055) and Multivitamins (Vitamin C+Vitamin E+ β-carotene) for Infertile MalesMale Infertility · Duta Wacana Christian University | Phase 4 | Active, not recruiting | Oct 25, 2023 |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
Roche